BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2567285)

  • 21. Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians.
    Gouda HM; Khorshied MM; El Sissy MH; Shaheen IA; Mohsen MM
    Ann Hematol; 2014 Aug; 93(8):1313-8. PubMed ID: 24627195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncogene rearrangement in non-Hodgkin's lymphoma with a 14q+ chromosome of unknown origin.
    Nakamine H; Masih AS; Chan WC; Sanger WG; Armitage JO; Weisenburger DD
    Leuk Lymphoma; 1993 May; 10(1-2):79-88. PubMed ID: 8374527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute lymphoblastic leukemia and non-Hodgkin's lymphoma with mediastinal mass--a study of 23 children; different disorders or different stages?
    Shikano T; Arioka H; Kobayashi R; Naito H; Ishikawa Y; Nakadate H; Hatae Y; Takeda T
    Leuk Lymphoma; 1994 Mar; 13(1-2):161-7. PubMed ID: 8025517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of maximum supportive care on dose compliance and survival. Single-center analysis of childhood acute lymphoblastic leukemia and non-Hodgkin's-lymphoma treated within 1984-1993.
    Urban C; Benesch M; Lackner H; Schwinger W; Kerbl R; Gadner H
    Klin Padiatr; 1997; 209(4):235-42. PubMed ID: 9293456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Family history of cancer in children with acute leukemia, Hodgkin's lymphoma or non-Hodgkin's lymphoma: the ESCALE study (SFCE).
    Rudant J; Menegaux F; Leverger G; Baruchel A; Nelken B; Bertrand Y; Hartmann O; Pacquement H; Vérité C; Robert A; Michel G; Margueritte G; Gandemer V; Hémon D; Clavel J
    Int J Cancer; 2007 Jul; 121(1):119-26. PubMed ID: 17330239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pattern of T-cell receptor delta gene rearrangement by Southern blotting and polymerase chain reaction technique in Hong Kong Chinese patients with non-T-cell hematological malignancies.
    Chan DW; Liang R; Kwong YL
    Hematol Oncol; 1996 Jun; 14(2):57-66. PubMed ID: 8876635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulation of growth of human malignant lymphoma and lymphoid leukemia cells in vitro.
    Strobel ES; Bross KJ; Mertelsmann R; Herrmann F
    Ann Hematol; 1992 Feb; 64(2):66-71. PubMed ID: 1554797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical applications of the study of immunoglobulin and T-cell receptor gene rearrangements in acute leukemia and non-Hodgkin's lymphoma in children].
    Schütt S; Seeger K; Henze G
    Klin Padiatr; 1990; 202(4):218-23. PubMed ID: 2395311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of cell cycle in acute leukemias and non-Hodgkin's lymphomas in children].
    Pituch-Noworolska A; Gawlicka M
    Acta Haematol Pol; 1993; 24(4):365-71. PubMed ID: 8303983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel restriction fragment length polymorphisms in the cellular oncogene SEA.
    Koduru PR; Goh JC; Broome JD
    Hematol Pathol; 1992; 6(2):71-8. PubMed ID: 1351480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methotrexate pharmacogenetics in Uruguayan adults with hematological malignant diseases.
    Giletti A; Vital M; Lorenzo M; Cardozo P; Borelli G; Gabus R; Martínez L; Díaz L; Assar R; Rodriguez MN; Esperón P
    Eur J Pharm Sci; 2017 Nov; 109():480-485. PubMed ID: 28887233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occult lymphoma cells prevalent in autologous marrow from non-Hodgkin's diffuse lymphoma.
    Yokoyama J; Fujimiya Y; Yamaguchi T; Shiga K; Saijo Y; Groveman DS; McBain JA; Suzuki Y; Ebina T
    Am J Hematol; 2003 May; 73(1):1-11. PubMed ID: 12701113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.
    Soucek P; Sarmanová J; Kristensen VN; Apltauerová M; Gut I
    Int Arch Occup Environ Health; 2002 Oct; 75 Suppl():S86-92. PubMed ID: 12397416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Restriction fragment length polymorphism of c-fos and c-src oncogene loci in spontaneously hypertensive (SHR) and control (WKY) rats].
    Kotelevtsev IuV; Brashishkite DA; Spitkovskiĭ DD; Postnov IuV
    Biull Eksp Biol Med; 1988 May; 105(5):585-6. PubMed ID: 2898265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein B gene polymorphism in a Russian population.
    Stepanov VA; Puzyrev VP
    Hum Biol; 1994 Jun; 66(3):527-31. PubMed ID: 7913079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.
    Bedewy AM; Mostafa MH; Saad AA; El-Maghraby SM; Bedewy MM; Hilal AM; Kandil LS
    J BUON; 2013; 18(1):227-38. PubMed ID: 23613410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncogene amplifications, rearrangements, and restriction fragment length polymorphisms in human leukaemia.
    Boehm TL; Hirth HP; Kornhuber B; Drahovsky D
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):623-9. PubMed ID: 2888656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Association of XRCC1 genetic polymorphism with susceptibility to non-Hodgkin's lymphoma].
    Li SX; Zhu HL; Guo B; Yang Y; Wang HY; Sun JF; Cao YB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):982-7. PubMed ID: 25130814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Genetic polymorphism and susceptibility to cancer].
    Larsen CJ
    Nouv Rev Fr Hematol (1978); 1988; 30(1-2):39-43. PubMed ID: 2898751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution of ABO blood groups in acute leukaemias and lymphomas.
    Vadivelu MK; Damodaran S; Solomon J; Rajaseharan A
    Ann Hematol; 2004 Sep; 83(9):584-7. PubMed ID: 15175895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.